CalciMedica, Inc. (CALC)

CalciMedica Income Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Selling, General & Admin	22.22	5.84	17.04	8.87	6.92
Research & Development	15.86	8.35	18.9	20.96	30.58
Operating Expenses	38.08	14.19	35.95	29.83	37.5
Operating Income	-38.08	-14.19	-35.95	-29.83	-37.5
Other Expense / Income	-3.72	-6.37	-0.13	-2.3	-0.47
Pretax Income	-34.36	-7.82	-35.82	-27.53	-37.04
Net Income	-34.36	-7.82	-35.82	-27.53	-37.04
Preferred Dividends	0	1.32	0	7.19	7.06
Net Income Common	-34.36	-9.14	-35.82	-34.72	-44.09
Shares Outstanding (Basic)	4	0	2	0	0
Shares Outstanding (Diluted)	4	0	2	0	0
Shares Change	5354.75%	-94.57%	220.31%	401.43%	-88.45%
EPS (Basic)	-7.66	-111.16	-23.66	-73.50	-467.74
EPS (Diluted)	-7.66	-111.16	-23.66	-73.50	-467.74
Free Cash Flow	-25.81	-11.76	-31.99	-33.09	-31.82
Free Cash Flow Per Share	-5.75	-143.00	-21.13	-69.99	-337.51
EBITDA	-34.3	-7.77	-35.3	-27.14	-36.73
Depreciation & Amortization	0.06	0.05	0.52	0.4	0.3
EBIT	-34.36	-7.82	-35.82	-27.53	-37.04

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).